Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Zafar

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
Neurology|November 30, 2021
Combining Transcranial Doppler and EEG Data to Predict Delayed Cerebral Ischemia After Subarachnoid HemorrhageHsin Yi Chen, Jonathan Elmer, Sahar F Zafar, et al.
Critical Care Medicine|October 12, 2021
Anisocoria and Poor Pupil Reactivity by Quantitative Pupillometry in Patients With Intracranial PathologyBrenton R Prescott, Hanife Saglam, Jonathan A Duskin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2020
Corrigendum to 'Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)': Annals of Oncology, Volume 31, Issue 1, 2020, Pages 79-87M Kundranda, A C Gracian, S F Zafar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)M Kundranda, A C Gracian, S F Zafar, et al.
Critical Care Explorations|July 5, 2022
Dexmedetomidine and Other Analgosedatives Alter Pupil Characteristics in Critically Ill PatientsWang Pong Chan, Brenton R Prescott, Megan E Barra, et al.
Neurocritical Care|April 5, 2020
Burden of Epileptiform Activity Predicts Discharge Neurologic Outcomes in Severe Acute Ischemic StrokeMohammad Tabaeizadeh, Hassan Aboul Nour, Maryum Shoukat, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
From Clinical Narrative to Diagnosis: Scalable Identification of Acquired EpilepsyJustin R Wheelock, Marta B Fernandes, Yilun Chen, et al.
Neurocritical Care|January 23, 2021
Electroencephalography, Hospital Complications, and Longitudinal Outcomes After Subarachnoid HemorrhageIndia A Lissak, Joseph J Locascio, Sahar F Zafar, et al.
JAMA Neurology|January 14, 2020
Assessment of the Validity of the 2HELPS2B Score for Inpatient Seizure Risk PredictionAaron F Struck, Mohammad Tabaeizadeh, Sarah E Schmitt, et al.
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
Dual-outcome Prediction of Post-Ischemic Stroke Epilepsy and Mortality Using Multimodal Quantitative BiomarkersYilun Chen, Alexandria L Soto, Tejaswi D Sudhakar, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Neurology|November 30, 2021
Combining Transcranial Doppler and EEG Data to Predict Delayed Cerebral Ischemia After Subarachnoid HemorrhageHsin Yi Chen, Jonathan Elmer, Sahar F Zafar, et al.
Critical Care Medicine|October 12, 2021
Anisocoria and Poor Pupil Reactivity by Quantitative Pupillometry in Patients With Intracranial PathologyBrenton R Prescott, Hanife Saglam, Jonathan A Duskin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2020
Corrigendum to 'Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)': Annals of Oncology, Volume 31, Issue 1, 2020, Pages 79-87M Kundranda, A C Gracian, S F Zafar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)M Kundranda, A C Gracian, S F Zafar, et al.
Critical Care Explorations|July 5, 2022
Dexmedetomidine and Other Analgosedatives Alter Pupil Characteristics in Critically Ill PatientsWang Pong Chan, Brenton R Prescott, Megan E Barra, et al.
Neurocritical Care|April 5, 2020
Burden of Epileptiform Activity Predicts Discharge Neurologic Outcomes in Severe Acute Ischemic StrokeMohammad Tabaeizadeh, Hassan Aboul Nour, Maryum Shoukat, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
From Clinical Narrative to Diagnosis: Scalable Identification of Acquired EpilepsyJustin R Wheelock, Marta B Fernandes, Yilun Chen, et al.
Neurocritical Care|January 23, 2021
Electroencephalography, Hospital Complications, and Longitudinal Outcomes After Subarachnoid HemorrhageIndia A Lissak, Joseph J Locascio, Sahar F Zafar, et al.
JAMA Neurology|January 14, 2020
Assessment of the Validity of the 2HELPS2B Score for Inpatient Seizure Risk PredictionAaron F Struck, Mohammad Tabaeizadeh, Sarah E Schmitt, et al.
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
Dual-outcome Prediction of Post-Ischemic Stroke Epilepsy and Mortality Using Multimodal Quantitative BiomarkersYilun Chen, Alexandria L Soto, Tejaswi D Sudhakar, et al.
Pageof 12